Cipher

CIP-Isotretinoin to be Distributed in the US

Cipher has granted Ranbaxy Pharmaceuticals Inc. (RPI) the exclusive right to market, sell and distribute CIP-Isotretinoin in the US. CIP-Isotretinoin is a patented formulation of isotretinoin, which is used in the treatment of severe nodular acne. T…

Cipher | 01 September 2008

• Cipher
• Ranbaxy
• CIP